The coronavirus could help pharma reset its reputation in Washington

  • STAT | by: Nicholas Florko |
  • 03/03/2020 12:00 AM
The coronavirus could help pharma reset its reputation in Washington
BIO says it has more than 20 companies pursuing coronavirus vaccines, therapeutics, or other products. Members like Moderna Therapeutics and Inovio are in the early stages of developing their own vaccines.

Drug industry critics, however, are unlikely to be impressed by pharma’s goodwill. Already, Democrats are insisting that drug makers should make any coronavirus treatment affordable. And the advocacy group Public Citizen has already criticized the drug industry for neglecting coronaviruses and vaccines more generally for more lucrative projects.

It’s also still too early to tell too whether Trump will be wooed by drug makers’ vaccine efforts and abandon his tough talk toward pharma, but drug industry defenders say it’s worth a shot.

“In a political season, telling politicians to put down really potent but incorrect and dangerous talking points may or may not be a fantasy,” said Peter Pitts, president of Center for Medicine in the Public Interest, which receives drug industry funding. “But it’s a battle worth fighting.”

 
Sign Up for Our Email Newsletter

RECENT NEWS

Drug shortages reaching record levels
  • Scripps News
  • 09/19/2023 12:00 AM

Drug shortages reaching record levels

Drug Shortages reaching record levels in the United States in nearly a decade...  Read more

When It Comes to FDA Communications

When It Comes to FDA Communications

Perhaps the most important lesson learned from the COVID-19 experience is that American health illiteracy kills....  Read more

Center for Medicine in the Public Interest Statement on ITC TRIPS Waiver Report
  • CMPI
  • 10/18/2023 12:00 AM

Center for Medicine in the Public Interest Statement on ITC TRIPS Waiver Report

Yesterday, the U.S. International Trade Commission published its report on possible expansion of the TRIPS waiver on Covi...  Read more

DRUGWONKS BLOG